Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07464574 · ClinicalTrials.gov registry record
Optimizing Non-statin Agents for ASCVD
A clinical trial of ASCVD Management, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT07464574: Recruiting study of ASCVD Management, sponsored by University of Texas at Austin.
NCT07464574 is a study of ASCVD Management that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07464574, a study of ASCVD Management, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
* The purpose of the study is to improve care for patients with high cholesterol. * If you choose to join the study, you will be asked to answer a phone call from study personnel. They will help you coordinate follow up appointments, review your medications and lab with you, and answer any questions you have about your medications. You will also continue to be seen by a clinical pharmacy team member. Your cholesterol medications may change to better lower your cholesterol. We will collect information about your visits, medicines, and cholesterol levels for 6 months. * If you choose not to participate, you will receive the same information and treatment at your next scheduled visit. You will receive the same care regardless of choosing to participate in the study. * Participation might involve a very low risk of some loss of privacy. There is low risk that someone outside the research study could see information about you. * A possible benefit is lower cholesterol. * Taking part in this research study is your choice. You do not have to participate, and you can stop at any time without any penalty.
Primary Outcome
To determine if pharmacy extenders' targeted outreach to patients with clinical ASCVD can result in a higher percentage of patients who are meeting LDL targets after 6 months of intervention
Conditions Studied
Interventions
- BEHAVIORAL Pharmacy Intern Counseling
Study Locations (1)
Texas
- CommUnityCare Health Centers - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-16 |
| Est. Completion | 2027-05-01 |
What NCT07464574 shows while recruiting
NCT07464574 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with ASCVD Management appearing as the primary indexed condition, and to 1 intervention - of which Pharmacy Intern Counseling is the first listed.
NCT07464574 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07464574 about?
NCT07464574 is a clinical study titled "Optimizing Non-statin Agents for ASCVD". * The purpose of the study is to improve care for patients with high cholesterol. * If you choose to join the study, you will be asked to answer a phone call from study personnel. They will help you coordinate follow up appointments, review your medications and lab with you, and answer any questions...
What is the current status of trial NCT07464574?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-01-16. Estimated completion is 2027-05-01.
What conditions does trial NCT07464574 study?
This clinical trial studies the following conditions: ASCVD Management.
What interventions are being tested in trial NCT07464574?
The interventions under investigation include: Pharmacy Intern Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT07464574?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07464574 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI